Market Highlights

• The National Science Foundation awarded Amplified Sciences a $275,000 Phase 1 SBIR grant to develop early, accurate tests for diseases like pancreatic cancer.
• Formation Bio, an AI-driven drug developer, raised $372.0 million dollars which will be used for acquiring and inlicensing candidate drugs and expanding their AI capabilities.
• The NYCEDC is progressing with its plans for the 1.5 million square foot (msf) SPARC life sciences development, releasing a request for proposal (RFP) as they enter the second phase of the ULURP process.

Read the full report